![Thomas Ulmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Ulmer
Direttore Finanziario/CFO presso
PYC THERAPEUTICS LIMITED
Profilo
Thomas Ulmer is currently Non-Executive Director at Aravax Pty Ltd. since 2020 and Chief Financial Officer at PYC Therapeutics Ltd. starting in 2026.
Formerly, Mr. Ulmer was Co-Managing Director at Immatics Biotechnologies GmbH from 2018 to 2020, Head-Planning, Forecasting & Resource Allocation at Merck KGaA from 2012 to 2016, Chief Financial Officer at Immatics NV, and Chief Financial Officer at Cell Therapies Pty Ltd. Education includes an MBA from the University of Giessen.
Posizioni attive di Thomas Ulmer
| Società | Posizione | Inizio |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direttore Finanziario/CFO | 07/07/2026 |
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Direttore/Membro del Consiglio | 01/11/2020 |
Precedenti posizioni note di Thomas Ulmer
| Società | Posizione | Fine |
|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Amministratore Delegato | 12/02/2020 |
| MERCK KGAA | Corporate Officer/Principal | 01/07/2016 |
Cell Therapies Pty Ltd. | Direttore Finanziario/CFO | - |
| IMMATICS N.V. | Direttore Finanziario/CFO | - |
Formazione di Thomas Ulmer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University of Giessen
 University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapies Pty Ltd. | |
Aravax Pty Ltd.
Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
